Introduction: Palmoplantar psoriasis (PPp) has a profound negative impact on patients’ quality of life, and it represents a therapeutic challenge, as palms and soles are diffcult to treat area. Although the effcacy profle of tildrakizumab has been well evaluated in the literature, data on its use for PPp are still limited. The objective of the study was to evaluate the effcacy and safety of tildrakizumab on moderate-to-severe plaque psoriasis with involvement of the palmoplantar area
Diotallevi, F., Esposito, M., Fargnoli, M.c., Quaglino, P., Mastorino, L., Stingeni, L., et al. (2025). Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study. DERMATOLOGY AND THERAPY [10.1007/s13555-025-01339-9].
Real-Life Experience with Tildrakizumab in Plaque Psoriasis with Palmoplantar Involvement: A Multi-Center Retrospective Italian Study
Bianchi, Luca;Galluzzo, Marco;
2025-01-01
Abstract
Introduction: Palmoplantar psoriasis (PPp) has a profound negative impact on patients’ quality of life, and it represents a therapeutic challenge, as palms and soles are diffcult to treat area. Although the effcacy profle of tildrakizumab has been well evaluated in the literature, data on its use for PPp are still limited. The objective of the study was to evaluate the effcacy and safety of tildrakizumab on moderate-to-severe plaque psoriasis with involvement of the palmoplantar area| File | Dimensione | Formato | |
|---|---|---|---|
|
23janDermatolTherapy.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
590.18 kB
Formato
Adobe PDF
|
590.18 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
